Abstracts tagged "inflammation and uveitis"

Abstract Number: 1252 • 2014 ACR/ARHP Annual Meeting
Intravenous Methylprednisolone Pulse Therapy in Severe Inflammatory Eye Disease. a Multicenter Study
Montserrat Santos-Gómez¹, Emma Beltrán², Vanesa Calvo-Río¹, Ricardo Blanco¹, Norberto Ortego³, Jose L. García Serrano⁴, Lucía Martínez Costa⁴, Alejandro Fonollosa⁵, Marisa Hernández⁶, Elia Valls⁷, Félix Francisco⁸, Miguel A. Reyes⁹, Ignacio Torre Salaberri¹⁰, Olga Maíz¹¹, Ana Blanco¹², Santiago Muñoz-Fernández¹³, M. Mar Esteban¹⁴, Esperanza Pato¹⁵, Manuel Díaz-Llopis¹⁶, Roberto Gallego¹⁶, Miguel Cordero¹⁷, Francisco Ortiz-Sanjuán¹, Joaquín Cañal Villanueva¹⁸, Leyre Riancho-Zarrabeitia¹ and Miguel A González-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ²Rheumatology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, ³Autoimmune Disease Unit, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ⁴Ophthalmology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ⁵Ophthalmology, Hospital de Cruces. Bilbao. Spain, Bilbao, Spain, ⁶Ophthalmology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, ⁷Rheumatology, Hospital Dr. Peset. Valencia. Spain, Valencia, Spain, ⁸Rheumatology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, ⁹Ophthalmology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, ¹⁰Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, ¹¹Rheumatology, Hospital Universitario de Donostia. San Sebastián. Spain, San Sebastián, Spain, ¹²Ophthalmology, Hospital Universitario de Donostia. San Sebastián. Spain, San Sebastián, Spain, ¹³Rheumatology, Hospital Infanta Sofía. San Sebastián de los Reyes. Spain, Madrid, Spain, ¹⁴Ophthalmology, Hospital Infanta Sofía. San Sebastián de los Reyes. Spain, Madrid, Spain, ¹⁵Rheumatology, Hospital Clínico San Carlos. Madrid. Spain, Madrid, Spain, ¹⁶Ophthalmology, Hospital Universitario La Fe. Valencia. Spain, Valencia, Spain, ¹⁷Ophthalmology, Hospital de León. Spain, León, Spain, ¹⁸Ophthalmology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain
Intravenous methylprednisolone pulse therapy in severe inflammatory eye disease. A Multicenter Study.Background/Purpose Treatment with high-dose intravenous methylprednisolone (IVMP) pulse therapy has proved to be effective…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].